Skip to content

Comparison the effect of Berberis vulgaris (in metronidazole base), Myrtus communis (in metronidazole base), and metronidazole vaginal gel alone in treatment of women with bacterial vaginosis

Comparison the effect of Berberis vulgaris (in metronidazole base), Myrtus communis (in metronidazole base), and metronidazole vaginal gel alone in treatment of women with bacterial vaginosis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201411102085N13
Enrollment
120
Registered
2014-12-07
Start date
2013-08-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute vaginitis. Acute vaginitis

Interventions

Intervention 1: Myrtus communis group: The intervention was conducted for 5 nights with vaginal gel consist of Myrtus communis 2% hydroalcoholic extract in metronidazole base. Berberis vulgaris gro
Treatment - Drugs
Myrtus communis group: The intervention was conducted for 5 nights with vaginal gel consist of Myrtus communis 2% hydroalcoholic extract in metronidazole base. Berberis vulgaris group: The interve
Control group: The intervention was conducted for 5 nights with metronidazole 0.75% vaginal gel alone.

Sponsors

Shahrekord Medical University of Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diagnosis of bacterial vaginosis according to Amsel’s criteria; married woman; age 18 to 40 years Exclusion criteria: Treatment with systemic or topical antibiotic in the last two weeks; menopause; pregnancy; hysterectomy; pelvic inflammatory disease; immune deficiency; diabetes mellitus; sensitivity to Myrtus communis or Berberis vulgaris

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Treatment of bacterial vaginosis. Timepoint: One week after treatment. Method of measurement: According to Amsel's criteria.

Secondary

MeasureTime frame
Relapse of bacterial vaginosis. Timepoint: Three weeks after treatment. Method of measurement: According to Amsel's criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Parvin

Shahrekord University of Medical Sciences

np285@yahoo.com+98 38 3333 5652

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 12, 2026